Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway

201687 citationsJournal Article

Authors

Good health and well-being

Published in: International Immunopharmacology

Volume 36, pp. 132-141

Field-Weighted Citation Impact: 6.44